Navigation Links
Vantia Therapeutics' Pipeline Continues to Mature
Date:3/24/2009

argeted therapy.

There has also been progress in Vantia Therapeutics' preclinical portfolio. The lead indications for the kallikrein inhibitor candidate VA118020, which moved into preclinical development at the end of last year, will be asthma and COPD. Clinical trials are expected to start in 2010. The company has also initiated a new programme involving an oral plasma kallikrein inhibitor which may have potential in the treatment of hereditary angioedema (HAE). HAE, which is thought to affect up to 15,000 people world wide, is characterised by episodes of swelling in various parts of the body including the airways. It can lead to pain, nausea, vomiting and death by asphyxiation, and an oral treatment would be expected to provide advantages over existing therapies.

Dr Jim Phillips, CEO of Vantia Therapeutics, said, 'Vantia is pleased to report that its two lead drug candidates continue to make clinical progress, and is looking forward to the trial results. As the next development steps proceed we will be engaging with potential partners for these products. In addition, our preclinical progress emphasises the ability of Vantia's small molecule library to populate our pipeline and our expertise in this area.'

Notes to Editors

About Vantia Therapeutics:

Vantia Therapeutics is a UK-based R&D company focused on first-in-class therapies for recognised markets which are underserved by current therapies. Formed in 2008 as a spin-out of Ferring Research Ltd's small molecule R&D, it has two clinical phase products, VA106483 for the treatment of nocturia in BPH patients and VA111913 for the treatment of dysmenorrhoea, as well as preclinical and discovery programmes based on protease inhibition with potential in the areas of oncology and inflammation. The company's investors include MVM Life Science Partners, SV Life Sciences and Novo A/S. Vantia Therapeutics is situated on Sou
'/>"/>

SOURCE Vantia Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  Air Products (NYSE: APD ) understands ... vital to any healthcare facility. This understanding has driven ... the efficiency of its oxygen supply systems, but also ... systems for emergency oxygen supply and high ... the 51 st ASHE Annual Conference & ...
(Date:7/28/2014)... Research and Markets  has announced the addition ... report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... to inflammation and pain in the human body,s joints such ... causes inflammation of the tissues that surround the joints and ... RA begin slowly, usually just mild pain around the joints ...
(Date:7/28/2014)... July 28, 2014  TNI BioTech, Inc. (OTCQB: ... focused on the development, marketing and distribution of ... definitive proxy materials with the Securities and Exchange ... of Shareholders to be held on Thursday, September ... The record date for determining those shareholders eligible ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3Global Rheumatoid Arthritis Drugs Market 2014-2018 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3
... Institute and Gallo Research Center today announced ... (SoRI-9409) will be published in the December ... publication is available online,today at the journal,s ... that,causes selective and long-lasting reduction in ethanol ...
... ALTO, Calif., Sept. 11 Jazz,Pharmaceuticals, Inc. (Nasdaq: ... participation in the first Phase III pivotal clinical trial,of ... The JZP-6 Phase III clinical trial program includes two ... patients at 65 centers in the U.S. The second ...
Cached Medicine Technology:Novel Compound Shows Promise for Treatment of Alcoholism 2Novel Compound Shows Promise for Treatment of Alcoholism 3Novel Compound Shows Promise for Treatment of Alcoholism 4Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia 2Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia 3
(Date:7/28/2014)... Co (PRWEB) July 28, 2014 Drorit ... has unveiled new plans to raise investment capital through ... 24/7 fitness concept in the United States. , According ... popularity of 24/7 fitness centers provide a great window ... this rapidly expanding space. In addition to this, Silverman ...
(Date:7/28/2014)... 2014 "Fist bumping" transmits significantly fewer bacteria ... the cultural expectation of hand-to-hand contact between patients ... the August issue of the American Journal ... the Association for Professionals in Infection Control and ... Institute of Biological, Environmental, and Rural Sciences at ...
(Date:7/28/2014)... 2014 The Wireline Services Market in Europe ... with analysis and forecast of revenue. The Wireline services market ... in 2013 to $2.4 billion by 2019, at a CAGR ... TOC of the Wireline Services Market in Europe report, to ... provides a glimpse of the segmentation in the European Wireline ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... to have a slightly increased risk of potentially fatal ... researchers report. Doctors have previously suspected that babies ... risk of deep vein thrombosis and pulmonary embolism, two ... the researchers noted in background information. This new ...
(Date:7/28/2014)... The Oneida Indian Nation today announced ... of accompanying PGA TOUR players will be teeing up ... Begay III for the seventh annual Notah Begay III ... Casino ’s Atunyote® Golf Club on Wednesday, August 27, ... Dufner, Jimmy Walker, Jonas Blixt, Angel Cabrera and Louis ...
Breaking Medicine News(10 mins):Health News:Pro Bodybuilder Drorit Silverman Confirms Plans to Raise Money for Investment in the Popular 24/7 Fitness Concept 2Health News:Fist-bumping beats germ-spreading handshake, study reports 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 2Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 2Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 5
... , ... embrace new technology. , ... MA (PRWEB) January 11, 2010 -- SonRidge, LLC, a catering and chef supplies company located ... for their clients in the food industry. What they discovered was an innovative resolution that ...
... ... and marketer of all-natural sunscreen products launched their website at solaraegis.com. , ... (PRWEB) January 13, 2010 -- ... products launched their website at www.solaraegis.com ., , , , ,"The site ...
... ... and financial security pet health insurance makes sense. Veterinarians once skeptical to the value ... insurance. , ... PA (PRWEB) January 14, 2010 -- Pet Health Insurance in the United States and ...
... ... stresses importance of greater awareness of brain injuries and serious lifelong implications for victims ... San Francisco, ... Year,s Day, in which top-ranked American snowboarder Kevin Pearce suffered a severe brain injury ...
... led by Professor Eduardo Franco, Director of McGill University,s ... colleagues from McGill and Universit de Montral/Centre Hospitalier de ... per cent) of young adults in a new sexual ... nearly half (44 per cent) were infected with an ...
... , , , NEW YORK ... a leading provider of software to public retirement organizations, announced ... System implementation for the State Teachers Retirements System of ... as a replacement to their legacy contributions, pension, disbursement, and ...
Cached Medicine News:Health News:Insulated Transport Containers Go Green 2Health News:SolarAegis, LLC. Website Helps You Have Fun In the Sun, Safely 2Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 2Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 3Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 4Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 5Health News:Snowboarding Accident Provides Tragic Reminder of Serious Risk of Brain Injuries in Athletic and Occupational Environments 2Health News:McGill-CHUM study: 56 percent of young adults in a new sexual relationship infected with HPV 2Health News:State Teachers Retirement System of Ohio Goes Live on V3 Benefits Administration System 2Health News:State Teachers Retirement System of Ohio Goes Live on V3 Benefits Administration System 3
...
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 23G x 5/8in (.60 x 16mm)...
... for LASIK surgery and other types of ... interface and/or stromal bed. Flattened tip provides ... elevate the flap edge. Multiple ports provide ... 22mm) Formed 9mm from end. Two .15mm ...
... for LASIK surgery and other types ... the corneal interface and/or stromal bed. ... the flap and helps elevate the ... irrigation. 21G x 7/8in (.80 x ...
Medicine Products: